Evidence map›Paper›PMID 27748719›Full record

ArticlePancreas2016

Chronic Pancreatitis in the 21st Century - Research Challenges and Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Aliye Uc, Dana K Andersen, Melena D Bellin, Jason I Bruce, Asbjørn M Drewes, John F Engelhardt, Christopher E Forsmark, Markus M Lerch, Mark E Lowe, Brent A Neuschwander-Tetri and 9 more

2 registry-linked trialsOpen access · greenAbstract readConference Proceedings
In one paragraph

Article in Pancreas, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03672422 completednot on this mapstarted 2017, after this paper: background citation

Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC) CPDPC16-03 Pediatric Longitudinal Cohort Study of Chronic Pancreatitis

Typeobservational_patient_registrySponsorAliye UcRan2017 to 2020Enrolled623ConditionsPancreatitis, Chronic, Pancreatitis, AcuteArmsBlood sample, Patient questionnaires, Saliva sample, Urine sample
NCT05775107 unknown statusnot on this mapstarted 2022, after this paper: background citation

Assessment of Pancreatic Fibrosis as a Prognostic Factor of Its Course

TypeobservationalSponsorMoscow Clinical Scientific CenterRan2022 to 2025Enrolled150ConditionsPancreatic Fibrosis
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Biomarkers of Chronic Pancreatitis: A systematic literature review.Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] · 2021
    Pooled it
  3. Chronic Pancreatitis: Role of Endoscopic Procedures.Digestive diseases and sciences · 2026
    Review
  4. Targeted therapeutics for pancreatitis.Frontiers in physiology · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. The phase 1/2 trial of indomethacin in chronic pancreatitis (The PAIR trial): Protocol for a parallel multi-center randomized controlled trial.Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] · 2023
    Article
  11. Review
  12. Deoxyhypusine synthase, an essential enzyme for hypusine biosynthesis, is required for proper exocrine pancreas development.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  13. Review
  14. Islet Function in the Pathogenesis of Cystic Fibrosis-Related Diabetes Mellitus.Clinical medicine insights. Endocrinology and diabetes · 2021
    Review
  15. Observational
  16. Article
  17. Article
  18. Review
  19. Higher Intra-Dialysis Serum Phosphorus Reduction Ratio as a Predictor of Mortality in Patients on Long-Term Hemodialysis.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 15 institutions in 4 countries.

Aliye UcFrom the *Division of Gastroenterology, Hepatology, Nutrition, Stead Family Department of Pediatrics, The University of Iowa, Iowa City, IA; †The Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD; ‡Departments of Pediatrics and Surgery, University of Minnesota Medical School, Minneapolis, MN; §Faculty of Life Sciences, University of Manchester, Manchester, UK; ∥Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark; ¶Department of Anatomy and Cell Biology, University of Iowa, Iowa City, IA; #Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Florida, Gainesville, FL; **Department of Medicine, University Medicine Greifswald, Greifswald, Germany; ††Division of Gastroenterology, Hepatology, Nutrition, Department of Pediatrics, Children's Hospital of Pittsburgh, Pittsburgh, PA; ‡‡Division of Gastroenterology and Hepatology, Saint Louis University, St Louis, MO; §§Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, PA; ∥∥Center for Child Health, Behavior, and Development, Seattle Children's Research Institute, University of Washington, Seattle, WA; ¶¶Division of Gastroenterology and Hepatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD; ##Department of Surgery, University of Miami Miller School of Medicine, Miami, FL; and ***Division of Gastroenterology, Hepatology and Nutrition, The Ohio State University Wexner Medical Center, Columbus, OH.
Dana K Andersen
Melena D Bellin
Jason I Bruce
Asbjørn M Drewes
John F Engelhardt
Christopher E Forsmark
Markus M Lerch
Mark E Lowe
Brent A Neuschwander-Tetri
Stephen J OʼKeefe
Tonya M Palermo
Pankaj Pasricha
Ashok K Saluja
Vikesh K Singh
Eva M Szigethy
David C Whitcomb
Dhiraj Yadav
Darwin L Conwell
University of Pittsburgh Medical Center · USJohns Hopkins Medicine · USAalborg University Hospital · DKChildren's Hospital of Pittsburgh · USNational Institute of Diabetes and Digestive and Kidney Diseases · USNational Institutes of Health · USSaint Louis University · USSeattle Children's Hospital · USThe Ohio State University Wexner Medical Center · USUniversitätsmedizin Greifswald · DEUniversity of Florida · USUniversity of Iowa · USUniversity of Manchester · GBUniversity of Miami · USUniversity of Minnesota Medical Center · US

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Natoshia M. Askelson · 2000 to 2026
$70.0M
Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Alejandro Antonio Pezzulo · 1998 to 2026
$30.5M
Year 9 Administrative Supplement to INSPPIRE 2U01DK108334 · NIDDK · UNIVERSITY OF IOWA · PI MARK E. LOWE, Aliye Uc · 2015 to 2026
$10.5M
Early Pathogenesis of Cystic Fibrosis Related DiabetesR24DK096518 · NIDDK · UNIVERSITY OF IOWA · PI ENGELHARDT, JOHN F, MORAN, ANTOINETTE M. · 2012 to 2018
$10.1M
U-01 CONSORTIUM FOR THE STUDY OF CHRONIC PANCREATITIS,DIABETES AND PANCREATIC CANCER CLINICAL CENTERSU01DK108320 · NIDDK · UNIVERSITY OF FLORIDA · PI CUSI, KENNETH, FORSMARK, CHRISTOPHER E · 2015 to 2024
$4.6M
Fatty Acid Defects & Oxidative Stress Modulate Islet Function in Cystic FibrosisR01DK097820 · NIDDK · UNIVERSITY OF IOWA · PI NORRIS, ANDREW W, UC, ALIYE · 2012 to 2016
$1.9M
INSPPIRE TO STUDY ACUTE RECURRENT AND CHRONIC PANCREATITIS IN CHILDRENR21DK096327 · NIDDK · UNIVERSITY OF IOWA · PI UC, ALIYE · 2012 to 2014
$586k
Medical Research CouncilNIDDK NIH HHS P30 DK054759NIDDK NIH HHS R01 DK097820NIDDK NIH HHS R21 DK096327NIDDK NIH HHS R24 DK096518NIDDK NIH HHS U01 DK108320NIDDK NIH HHS U01 DK108334Wellcome Trust
6 · The paper itself

Abstract

A workshop was sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases to focus on research gaps and opportunities in chronic pancreatitis (CP) and its sequelae. This conference marked the 20th year anniversary of the discovery of the cationic trypsinogen (PRSS1) gene mutation for hereditary pancreatitis. The event was held on July 27, 2016, and structured into 4 sessions: (1) pathophysiology, (2) exocrine complications, (3) endocrine complications, and (4) pain. The current state of knowledge was reviewed; many knowledge gaps and research needs were identified that require further investigation. Common themes included the need to design better tools to diagnose CP and its sequelae early and reliably, identify predisposing risk factors for disease progression, develop standardized protocols to distinguish type 3c diabetes mellitus from other types of diabetes, and design effective therapeutic strategies through novel cell culture technologies, animal models mimicking human disease, and pain management tools. Gene therapy and cystic fibrosis conductance regulator potentiators as possible treatments of CP were discussed. Importantly, the need for CP end points and intermediate targets for future drug trials was emphasized.

Indexed as

Pancreatitis, ChronicAnimalsDiabetes MellitusHumansMutationNational Institute of Diabetes and Digestive and Kidney Diseases (U.S.)TrypsinTrypsin Inhibitor, Kazal PancreaticTrypsinogenUnited StatesTrypsinTrypsin Inhibitor, Kazal PancreaticTrypsinogen

Identifiers

PMID27748719
PMCPMC5117429
OpenAlexW2526450495

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.